Please provide your email address to receive an email when new articles are posted on . A live biotherapeutic product significantly reduced the risk for recurrent BV in women who were clinically cured ...
Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results